Adaptive Biotechnologies Corporation

NASDAQ:ADPT

4.78 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -225.25-200.368-207.298-146.227-68.606-46.447-42.831
Depreciation & Amortization 22.23120.9213.9538.4727.79165.796
Deferred Income Tax -60.9207.2330.773-1.881-1.2430.637
Stock Based Compensation 62.90855.47743.25124.76113.12411.1497.009
Change In Working Capital -46.183-71.546-56.816-40.799254.933-1.723-5.475
Accounts Receivables 2.032-22.648-7.3622.613-7.8170.775-2.427
Inventory -2.8380.817-5.2-4.994-1.231-3.046-2.697
Accounts Payables -5.4077.1115.2265.247-2.4271.867-1.844
Other Working Capital -39.97-56.826-49.48-43.665266.408-1.3191.493
Other Non Cash Items 90.8911.5726.953.3370.0430.0050.006
Operating Cash Flow -156.324-183.945-192.727-149.683205.404-32.259-34.858
Investing Activities:
Investments In Property Plant And Equipment -10.697-16.349-61.746-18.803-11.2-6.318-2.506
Acquisitions Net 0-19.254-181.2198.241470.4970.0190.085
Purchases Of Investments -429.558-278.778-316.544-694.965-884.217-146.503-125.182
Sales Maturities Of Investments 569.902298.032559.5596.724413.72153.538163.913
Other Investing Activites -019.254181.21-98.241-470.4970.0190.122
Investing Cash Flow 129.6472.905181.21-117.044-481.6970.73636.432
Financing Activities:
Debt Repayment 0-124.37500000
Common Stock Issued 2.2457.8926.717272.16320.851.26850.049
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 2.245248.7527.14621.427-0.9341.24850.034
Financing Cash Flow 2.245132.26527.146293.587319.9161.24850.034
Other Information:
Effect Of Forex Changes On Cash -201.32000000
Net Change In Cash -24.966-48.77515.62926.8643.623-30.27551.608
Cash At End Of Period 65.06492.428141.203125.57498.71455.09185.366